CONMED Corp·4

May 2, 4:19 PM ET

Jonas Daniel S 4

4 · CONMED Corp · Filed May 2, 2023

Insider Transaction Report

Form 4
Period: 2023-04-28
JONAS DANIEL
VP Legal Affairs, Gen. Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-28$97.69/sh+10,000$976,90023,462 total
  • Sale

    Common Stock

    2023-04-28$126.72/sh4,300$544,89613,662 total
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-2810,00010,000 total
    Exercise: $97.69Exp: 2030-03-02Common Stock (10,000 underlying)
  • Gift

    Common Stock

    2023-04-2862613,462 total
  • Sale

    Common Stock

    2023-04-28$125.57/sh5,500$690,63517,962 total
  • Sale

    Common Stock

    2023-04-28$127.56/sh200$25,51213,462 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F4]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT